July 31, 2026 01:55 AM GMT PTC Therapeutics | North America 2Q26 Update: Sephience-Driven Increase in FY Sales | What's Changed | | | | --- | --- | --- | | PTC Therapeutics (PTCT.O) | From | To | | Price Target | $93.00 | $104.00 | AlphaSignals Earnings Reaction Unchanged Modest upside Modest revision higher Impact to our thesis Financial results versus consensus Direction of next 12-month consensus EPS Source: Company data, Morgan Stanley Research Key Takeaways PTC provided its 2Q update with Sephience per ...